Navigation Links
Acura Pharmaceuticals, Inc. Announces Implementation of Reverse Stock Split and New Trading Symbol: ACPH
Date:12/4/2007

PALATINE, Ill., Dec. 4 /PRNewswire-FirstCall/ -- Acura Pharmaceuticals, Inc. (OTC Bulletin Board: ACUR) today announced the filing of an amendment to its Certificate of Incorporation effecting a 1 for 10 reverse stock split. Commencing December 5, 2007, the Company's common stock will trade on a split adjusted basis under the symbol "ACPH". The Company's intent to effect a reverse stock split was announced on October 31, 2007 and was subject to meeting certain OTC Bulletin Board requirements which have now been met.

Objectives of the Reverse Stock Split

The Company's primary objectives for implementing the reverse stock split are to reduce the number of outstanding common shares to be generally consistent with comparable companies and attempt to raise the per share trading price of its common stock in an effort to obtain a listing on the American Stock Exchange ("AMEX") or the Nasdaq Capital Market ("NASDAQ"). While the Company intends that the reverse split will increase the bid price per share of its common stock above the minimum prices required for listing by AMEX and NASDAQ, there can be no assurance that the reverse split will have that effect, initially or in the future, or that it will enable the Company to achieve the listing of its common stock on the AMEX or the NASDAQ. In addition, there can be no assurance that the price per share of the Company's common stock immediately after the reverse split will increase proportionately with the reverse split or that any price per share increase will be sustained for any period of time.

Impact of Reverse Stock Split on Number of Shares Held

Shareholders of record will be entitled to receive a new stock certificate representing the number of shares calculated by dividing their pre-split share holdings by 10. If the total number of pre-split shares that a shareholder holds is not evenly divisible by 10, the shareholder will receive cash in an amount equal to the fraction of a share
'/>"/>

SOURCE Acura Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acuras Aversion(R) (Abuse-Deterrent) Technology
2. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
5. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
6. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
7. ACG Announces Major Gift by Salix Pharmaceuticals, Inc.
8. Anthera Pharmaceuticals, Inc. Appoints Donald Santel to Board of Directors
9. Elan Pharmaceuticals, Inc. Licenses Software and Databases From GeneGo
10. Jazz Pharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
11. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ients with liver lesions, researchers find , ...ng the drug cetuximab to neoadjuvant chemotherapy ... surgery in colorectal cancer patients with inoper...ts. , , Tumors spread to other parts of the bo...ancer. Most commonly, the cancer spreads to the li...
(Date:11/25/2009)...njoy festive feasting , , WEDNESDAY, Nov... holiday smorgasbord from Thanksgiving to New Year...ds you,ll have to sweat off come Jan. 1, help is a... to enjoy holiday eating and make it to 2010 wei...ut devising a strategy and thinking about holiday ...
(Date:11/25/2009)...students to use natural treatments to complement c...rnaby, BC (Vocus) November 25, 2009 -- While surge...ffective treatments in the fight against cancer, p... them cope with the side effects of conventional t...nts using acupuncture and herbal medicine, it is i...
(Date:11/25/2009)...er.comannouncesthatanewmarketresearchreportisavail...gFoods(2ndEdition) ,, http://www.reportlinke...nd-Edition ).html ,, Theglobalfunctionalfoodsma...ppingthatofconventionalfoods,andproductinnovationr...approachtohealthclaimshoweverwillclearlyinfluencet...
(Date:11/25/2009)...ries,the headlice helpers( www.hairfairies.com...hanksgivingNitZapping(TM)giveaway.Thefirst100calle...heirchoiceofafree,allnatural,Nit-Zapping(TM)shampo...ffer50%offitswholerangeofsafe,non-toxicproductsthr...nline. ,, Theholidaysareawonderfuloccasionforfa...
Breaking Medicine News(10 mins):Health News:Cetuximab Helps Treat Colorectal Cancer 2Health News:Holiday Eating Without the Guilt -- or the Pounds 2Health News:Holiday Eating Without the Guilt -- or the Pounds 3Health News:Holistic and Western Medicine Combined Can Fight Cancer 2Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 2Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 3Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 4Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 5Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 6Health News:Hair Fairies Kicks Off the Holiday Season With an All Natural Head Lice Product Giveaway 2Health News:Hair Fairies Kicks Off the Holiday Season With an All Natural Head Lice Product Giveaway 3
...INGTON, March 10 Give an Hour, (http://www.givean...n offering free,mental health services to returnin...re are now 1,000 providers, nationwide, on its net...,services are available to the service member, the...
...Washington, DC (March 5, 2008): Addressing questio...r concerns expressed by young voters in a recent s... to Elections, a science and technology policy gui...th issues and provide them with the platforms of t...
...idates for less radical procedures may not be gett...(HealthDay News) -- A surgeon,s skills and prefere...er more than clinical factors such as tumor size o...ial nephrectomy where only part of the kidney is r...
... than 100 Latino leaders in California participate... expected to become the largest ethnic group by 20...2040. One third of the Latino community in,Califor...atino community is immigration, there seems to be ...
...tes Innovative, Inviting, Child-Friendly Online In..., and Healthcare Professionals ...March 10 Siegel+Gale, one of the world,s,premier ...ly find online resources about childhood cancer, b...
...hen space shuttle Endeavor blasts off on March 11,...perimental payload from Arizona State Universitys ...Microbial Drug Resistance Virulence is part of the...s Center for Infectious Diseases and Vaccinology. ...
Other Medicine News:Health News:1,000 Mental Health Professionals Join National Network to Provide Free Counseling to Returning Veterans and their Families 2Health News:Student Pugwash USA launches science policy election guide for young voters 2Health News:Surgeon's Preferences Dictate Choice of Kidney Cancer Surgery 2Health News:Surgeon's Preferences Dictate Choice of Kidney Cancer Surgery 3Health News:New Survey Shows Solutions to Improve Latinos' Access to Health Care in California 2Health News:Siegel+Gale Designs New 'HOPE Portal' for Childrens Hospital Los Angeles 2Health News:Siegel+Gale Designs New 'HOPE Portal' for Childrens Hospital Los Angeles 3Health News:Microscopic 'astronauts' to go back in orbit 2Health News:Microscopic 'astronauts' to go back in orbit 3
(Date:11/24/2009)...A,Md.,Nov.24/PRNewswire-Asia/--ChindexInternationa...entAmericanproviderofWestern,healthcareproductsand...edthattheCompanywillattendthe21stAnnualPiperJaffra...1-2,2009,atthe,NewYorkPalaceHotel. , Manageme...y,December1,2009,andholdone-on-onemeetingsthrough...
(Date:11/24/2009)...O,Nov.24/PRNewswire-FirstCall/--AnadysPharmaceutic...sentatthe21stAnnualPiperJaffrayHealthcareConferenc...).TheconferenceisbeingheldatTheNewYorkPalaceHotel....erofAnadys,willprovideanoverviewofAnadysanditsclin...corporatepresentationwillbesimultaneouslywebcastan...
(Date:11/24/2009)...D,Conn.,Nov.24/PRNewswire/--ZargisMedicalCorp.,asu...romSiemensCorporateResearch(NYSE: SI ),todayannoun...vember24,2009episodeofCBS, TheEarlyShow duringaseg...agazine,reviewedfivewinningproductsfromthepublicat...how isawidely-viewedtelevisionmorningnewstalkshowb...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 3Hill Rom Announces Corporate Governance Enhancements 5270 1Hill Rom Announces Corporate Governance Enhancements 5270 2Hill Rom Announces Corporate Governance Enhancements 5270 3Hill Rom Announces Corporate Governance Enhancements 5270 4Foundation Radiology Group Adds Shawn Kramer Director of Client Services 5268 1Foundation Radiology Group Adds Shawn Kramer Director of Client Services 5268 2CareFusion Earns Top Ranking in MD Buyline and KLAS Reports 5266 1CareFusion Earns Top Ranking in MD Buyline and KLAS Reports 5266 2CareFusion Earns Top Ranking in MD Buyline and KLAS Reports 5266 3
... Calif., June 9 Alexza,Pharmaceuticals, Inc. (Nas...rom its Phase 2a proof-of-concept clinical trial w...th panic disorder. The study did not meet its two,... on the incidence of a,doxapram-induced panic atta...oxapram-induced panic attack, both as compared wit...
...s., June 9 Peptimmune, Inc., a privately,held bio...ts from its,PI-2301 peptide copolymer program at b...d at FOCIS 2008 in Boston, MA. The Company present...irst-in-man study involving,healthy, male adult vo...-generation peptide copolymer PI-2301. This study ...
Other Medicine Technology:Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder 2Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder 3Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder 4Peptimmune Presents Early Clinical Data at European Neurological Society and Federation of Clinical Immunology Societies Meetings 2Peptimmune Presents Early Clinical Data at European Neurological Society and Federation of Clinical Immunology Societies Meetings 3
Vortex Adapter for Vortex Genie 2, holds (12) 2 ml tubes
...V-500 with Vacuum Controller V-800 and water-coole...m levels from Model V-500 is a powerful PTFE me...applications. Applications Ideally suited for u...vacuum source for instruments including vacuum ove...
...V-500 with Vacuum Controller V-800 Efficiently c...mechanism turns V-500 on and off as needed to main...ful PTFE membrane vacuum pump designed to handle m...uited for use with up to two rotary evaporators ...
...m System UVS400 is a multi-tasking vacuum source a...refrigerated vapor trap and a maintenance-free, oi...e easy-to-use, wide-mouth glass condensation flask...r for easy disposal. The UVS400 provides an ideal ...
Medicine Products: